BioLab Sciences announces patent for regenerative tissue therapy, MyOwn Skin™

Posted on 24 October 2019

In the United States alone, chronic wounds affect 6.5 million patients. Our advanced, tissue-biomanufacturing approach offers a viable, effective solution for skin regeneration and repair. This innovative strategy has shown to accelerate the healing of damaged soft tissue and improve wound-care outcomes.

Bob Maguire, Biolab Sciences CEO

Arizona-based biotech startup, BioLab Sciences, an innovator in regenerative medicine technologies, has recently announced a painless, non-surgical procedure, which utilises a patient’s own skin to produce full-thickness skin grafts in 5-7 days

MyOwn Skin™ aims to accelerate the healing of chronic wounds, burns, diabetic foot ulcers and other difficult-to-heal wounds. They claim that they can take a small skin sample, no bigger than a fingernail, and within about a week are able to three square patches of new skin, each measuring about 4×4 inchs. This will accelerate the wound repair and healing process by a matter of months.

Featured in This Post

Never Miss a Breakthrough!

Sign up for our newletter and get the latest breakthroughs direct to your inbox.

Checkout the Gowing Life Store

Scientifically Developed Blended Vitamins, and Exclusive Supplements For Health, and Longevity

Copyright © Gowing Life Limited, 2022 • All rights reserved • Registered in England & Wales No. 11774353 • Registered office: Ivy Business Centre, Crown Street, Manchester, M35 9BG.